Cargando…
Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
BACKGROUND: Proton pump inhibitors (PPIs) contribute to polypharmacy and are associated with adverse effects. As prospective data on longitudinal patterns of PPI prescribing in older patients with multimorbidity are lacking, we sought to assess patterns of PPI prescribing and deprescribing, as well...
Autores principales: | Aubert, Carole E., Blum, Manuel R., Gastens, Viktoria, Dalleur, Olivia, Vaillant, Fanny, Jennings, Emma, Aujesky, Drahomir, Thompson, Wade, Kool, Tijn, Kramers, Cornelius, Knol, Wilma, O’Mahony, Denis, Rodondi, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981164/ https://www.ncbi.nlm.nih.gov/pubmed/36854455 http://dx.doi.org/10.9778/cmajo.20210240 |
Ejemplares similares
-
Predictors of 1‐year drug‐related admissions in older multimorbid hospitalized adults
por: Aubert, Carole E., et al.
Publicado: (2022) -
HOSPITAL Score and LACE Index to Predict Mortality in Multimorbid Older Patients
por: Aubert, Carole E., et al.
Publicado: (2022) -
Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With Multimorbidity
por: Schneider, Claudio, et al.
Publicado: (2022) -
Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients
por: Papazoglou, Dimitrios David, et al.
Publicado: (2021) -
Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial
por: Sibille, François-Xavier, et al.
Publicado: (2023)